Skip to main content
OpenTrials
Completed

NCT Number: NCT00794079

Omega-3 Fatty Acids and Muscle Protein Synthesis

The purpose of this study is to determine whether omega-3 fatty acid supplementation influences muscle protein synthesis rates in young and older adults.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Washington University in Saint Louis

St Louis, Missouri, 63110, United States

About this study

Loss of muscle mass is a normal consequence of aging. The decline in muscle mass is estimated to be 0.2-0.5% per year from 60 years old onwards in healthy subjects with the decline worsened by chronic illness, poor appetite and diet, and reduced physical activity in the elderly. Increased morbidity is demonstrable with as little as a 5% loss of muscle mass - therefore, treatments that can prevent or slow the progression of muscle loss with aging are much desired.

A major cause for loss of muscle mass in advanced age appears to be an impaired ability to stimulate the synthesis of muscle protein in response to increased levels of amino acids (the building blocks of proteins) and insulin as occurs after eating because of low-grade inflammation and insulin resistance in muscle of old persons. We propose that long-chain omega-3 polyunsaturated fatty acids (fish oil) slow the loss of muscle mass because fish oil has anti-inflammatory properties and increases the sensitivity of muscle protein synthesis to insulin and amino acids. We will test this by studying the effect of fish oil supplementation on the muscle protein synthesis process in young and older adults.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Body mass index (BMI) < 30 kg/m2;
  • Age 18-45 yr; or
  • Age 65-85 yr

Exclusion criteria

  • Those taking medications known to affect substrate metabolism or medications that may confound the findings from our study (synthetic steroids, glucocorticoids etc.);
  • Those with evidence of significant organ system dysfunction (e.g. diabetes mellitis, cirrhosis, hypo- or hyperthyroidism; hypertension);
  • Body mass index > 30 kg/m2
  • Age <18 yr, 45-65 yr or > 85 yr
  • Those performing >1.5h of exercise/wk

Treatment and study plan

Omega-3 fatty acids

Dietary Supplement

4 grams per day for 8 weeks

Other names: Lovaza

corn oil

Dietary Supplement

4 grams per day for 8 weeks

Primary outcomes

  1. Evaluate the effect of omega-3 fatty acid supplementation on skeletal muscle protein synthesis rates both in the basal, postabsorptive state and in response to infusion of insulin and amino acids in young and older adults

    Time frame: Measurements taken prior to and following 8 weeks of supplementation

Secondary outcomes

  1. Evaluate the effect of omega-3 fatty acid supplementation on anabolic signaling pathways in skeletal muscle

    Time frame: Measurements taken prior to and following 8 weeks of supplementation

  2. Evaluate the effect of omega-3 fatty acid supplementation on inflammatory cytokines in the systemic circulation and inflammatory signaling pathways in skeletal muscle

    Time frame: Measurements taken prior to and following 8 weeks of supplementation

  3. Compare muscle protein synthesis rates between men and women in the basal, postabsorptive state and in response to insulin and amino acid infusion

    Time frame: prior to supplementation only

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • American Federation for Aging Research
  • Longer Life Foundation
  • Reliant Pharmaceuticals

Registry information

Important dates

Study start
2007
Primary completion
2010
Study completion
2010
First posted
Nov 19, 2008
Registry last updated
Aug 3, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.